Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

15.510
+1.97014.55%
Volume:25.00M
Turnover:378.76M
Market Cap:27.41B
PE:34.91
High:15.670
Open:13.530
Low:13.380
Close:13.540
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:3.82
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.444
ROE:12.77%
ROA:4.28%
PB:3.06
PE(LYR):34.91
PS:8.43

Loading ...

Xie Zhiyu's Q1 Portfolio Revealed: Increased Bets on Chemical and Energy Storage Sectors

Stock News
·
Apr 21

InnoCare Pharma Sets 23 April Board Meeting to Approve Q1 2026 Unaudited Results

Bulletin Express
·
Apr 10

Assessing InnoCare Pharma (SEHK:9969) Valuation After Its 2025 Profit Turnaround

Simply Wall St.
·
Apr 08

Innocare Pharma Reports Annual Revenue of 23.75 Billion Yuan with 642 Million Yuan Net Profit; King Bridge Exits Entire Stake Potentially Realizing Over 2 Billion Yuan

Deep News
·
Apr 07

Goldman Sachs Slightly Raises Innocare Target to HK$19.93 on Strong Q4 Sales of Orelabrutinib

Stock News
·
Mar 30

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum

Simply Wall St.
·
Mar 30

The InnoCare Pharma Limited (HKG:9969) Yearly Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.
·
Mar 28

Stock Track | InnoCare Pharma Soars 5.08% Intraday on Strong Q4 Profit Surge

Stock Track
·
Mar 27

InnoCare Pharma (SEHK:9969) Q4 Profit Surge Challenges Bearish Earnings Narratives

Simply Wall St.
·
Mar 26

UBS Trims Innocare Pharma Target to HK$19.8, Keeps Buy Rating

Stock News
·
Mar 26

Press Release: InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit

Dow Jones
·
Mar 25

InnoCare Pharma Turns to 2025 Profit

MT Newswires Live
·
Mar 25

InnoCare Updates Nomination Committee Charter to Strengthen Board Oversight and Diversity

Bulletin Express
·
Mar 25

InnoCare Pharma Publishes Updated Terms of Reference for Compensation Committee

Bulletin Express
·
Mar 25

InnoCare Proposes Sixth Amended Articles to Introduce Treasury Shares, Hybrid Meetings and E-Dividends

Bulletin Express
·
Mar 25

InnoCare Pharma Updates Audit Committee Charter to Strengthen Financial Oversight and Governance

Bulletin Express
·
Mar 25

InnoCare Announces Company Secretary Transition Effective 25 March 2026

Bulletin Express
·
Mar 25

INNOCARE Announces Appointment of Lian Shao'e as Company Secretary and Authorized Representative

Stock News
·
Mar 25

Innocare Reports 2025 Financial Results: Achieves Profitability with Net Income of Approximately 644 Million Yuan

Stock News
·
Mar 25

InnoCare redistributes RMB 2.78 billion STAR-Market IPO funds; key R&D project ICP-248 receives larger allocation

Bulletin Express
·
Mar 25